Learn about BYETTA, the BYETTA Pen. in patients with prior severe hypersensitivity reactions to exenatide or to any of the product components. Patient Information Leaflet. Package leaflet: Information for the patient. Byetta 5 micrograms solution for injection in pre-filled pen. Byetta 10 micrograms solution . Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Byetta (Exenatide).
|Published (Last):||14 November 2013|
|PDF File Size:||1.24 Mb|
|ePub File Size:||12.83 Mb|
|Price:||Free* [*Free Regsitration Required]|
Byetta package insert Uses BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise. The Double B logo is a trademark of the AstraZeneca group of companies. Byetta package insert your html here Staying Active Learn how regular physical activity can help you manage type 2 diabetes.
Insedt with caution with medications that have a narrow therapeutic index or require rapid gastrointestinal absorption. All other trademarks are property of their respective owners. Your risk for getting low blood sugar hypoglycemia is byeta if you take BYETTA with byetta package insert medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Not a substitute for insulin and should not be used in patients with type 1 diabetes or diabetic ketoacidosis.
Should not byetta package insert used in patients with severe renal impairment or end-stage renal disease.
Inflammation of the pancreas pancreatitis may happen, which may be severe and lead to death. You may give other people a serious infection, or get a serious infection from them. BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, based on postmarketing byetta package insert.
All other trademarks are property of byetta package insert respective owners. These may be symptoms of pancreatitis.
Call your healthcare provider byetta package insert away if you have nausea, vomiting, or diarrhea that will not go away, or if you cannot take liquids by mouth.
BYETTA slows gastric emptying and can reduce the extent and rate of absorption of orally administered drugs. BYETTA is an injectable prescription medicine byetta package insert may improve blood sugar glucose control in adults with type byetta package insert diabetes, when used with diet and exercise.
BYETTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The site you are about to visit is maintained by a third party who is solely responsible pac,age its contents. Tell your healthcare provider if you are pregnant or plan to become pregnant. Because exenatide is commonly associated with gastrointestinal adverse reactions, BYETTA is not recommended in patients with severe gastrointestinal disease eg gastroparesis. Glucagon-like indert receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes.
Tell your healthcare inseft if you have severe problems with your stomach, such byetta package insert delayed emptying of your stomach gastroparesis or problems with digesting food. If pancreatitis is suspected, BYETTA should be discontinued promptly and should not be restarted if pancreatitis gyetta confirmed.
No placebo-treated patients withdrew due to nausea or vomiting.
Drug Interactions Oral Medications: Postmarketing reports of altered renal function, including increased serum creatinine, renal impairment, worsened chronic renal failure, and acute renal failure, sometimes requiring hemodialysis and kidney transplantation. Based on postmarketing data BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis. Patients may develop antibodies to exenatide. Tell your healthcare provider if you have or had kidney problems or a kidney transplant.
Stop taking BYETTA and call your healthcare provider byetta package insert away if you have pain in byetta package insert stomach area abdomen that is severe, and will not go away, occurs with or without vomiting or is felt going byetfa your abdomen through to your back. Before taking BYETTA, tell your insedt provider if you have had pancreatitis, stones in your gallbladder gallstonesa history of alcoholism, or high blood triglyceride levels.
Go to Patient Site. To report drug exposure during pregnancy call Talk to your healthcare provider first if you are breastfeeding or plan to breastfeed. This product information is intended byetta package insert US Healthcare Professionals only.
Use in pediatric patients is not recommended as safety and effectiveness have not been established.
After initiation and byetta package insert increases of BYETTA, observe patients carefully for pancreatitis including persistent severe abdominal pain, sometimes radiating to the back, with or without vomiting.
Oral medications dependent on threshold concentrations for efficacy, such as contraceptives or antibiotics, should be taken at least 1 hour before BYETTA. Postmarketing byetta package insert of increased international normalized ratio INR sometimes associated with bleeding with concomitant use of warfarin. Signs and symptoms of low blood sugar may include headache, drowsiness, weakness, dizziness, confusion, irritability, hunger, fast heartbeat, sweating, and feeling jittery.
FDA Internet Application Site (Accessdata) Error
Based on animal data, BYETTA may cause packaage harm and should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Postmarketing reports byetta package insert serious hypersensitivity reactions eg anaphylaxis and angioedema.
You may report side effects related to AstraZeneca products by clicking here. The most frequently reported adverse reactions leading to withdrawal for Byetta-treated patients were nausea 5.
Add BYETTA to insulin glargine as a complementary action to help improve glycemic control
AstraZeneca provides this link as a service to website visitors. Concurrent use with prandial byetta package insert has not been studied and cannot be recommended. Packzge clinical studies establishing conclusive evidence of macrovascular risk reduction with BYETTA or any other antidiabetic drug.